Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine vs Desloratadine in Seasonal Allergic Rhinitis
NCT00160537Phase 4Completed
- Sponsor
- UCB
- Start
- May 2005
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of levocetirizine in seasonal allergic rhinitis (SAR) (2 arms), sponsored by UCB. Primary endpoint: Subjects' satisfaction / dissatisfaction after the first week of treatment at 1 week. Started May 2005; status: completed.
02
Drugs
levocetirizine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00160537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160537.